Is point-of-care (POC) coagulation testing worthwhile before regional or neuraxial anesthesia?

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

A 58-year-old man is brought into the trauma center with a crush injury of his bilateral lower extremities after a steel beam fell on him at a construction site. After responding to the page reporting the level-1 trauma, you evaluate whether the patient will need to go to the operating room (OR) emergently. Arriving at the trauma unit, you get a report from the emergency medical services (EMS) stating that this man has a history of coronary artery disease (CAD) with a drug-eluting stent (DES) placed 8 months ago and that he is on both aspirin and clopidogrel. The patient is obese, with a Mallampati IV airway, and has obstructive sleep apnea (OSA). This chapter will review point of care coagulation testing and its role in regional and neuraxial anesthesia.

Original languageEnglish
Title of host publicationYou're Wrong, I'm Right
Subtitle of host publicationDueling Authors Reexamine Classic Teachings in Anesthesia
PublisherSpringer International Publishing
Pages337-338
Number of pages2
ISBN (Electronic)9783319431697
ISBN (Print)9783319431673
DOIs
StatePublished - 1 Jan 2016
Externally publishedYes

Keywords

  • Anticoagulation
  • Neuraxial anesthesia
  • Point-of-care (POC) coagulation testing
  • Regional anesthesiology
  • Trauma anesthesiology

Fingerprint

Dive into the research topics of 'Is point-of-care (POC) coagulation testing worthwhile before regional or neuraxial anesthesia?'. Together they form a unique fingerprint.

Cite this